Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Press releases
Media kit
Innovation Awards
Articles
Navigating pharma’s leap into the predictive plant era
April 25, 2024
Real-time predictive analysis is the key to digital plant maturity
Editors' (re)View: A new obesity startup; Schizophrenia treatment happenings
April 19, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of April 15.
Pharma's molecular glue garden
April 16, 2024
With key players entering the ring and many clinical trials underway, the molecular glue garden is bound to bloom soon
Editors' (re)View: Advancing mental health treatment; CMS proposes financial incentives for gene therapy access
April 12, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of April 8
Batch process understanding for process validation and quality control
April 11, 2024
A first-of-its-kind study of isotopic values of paired reactants and products offers a prospective new method of process understanding
The pharma manufacturing facility of the future
April 10, 2024
The challenges are surmountable — and worth taking on to help build advantages
The state of pharma manufacturing
April 9, 2024
A recent industry revenue report found that effective data use is key in pharma, yet underexploited
Strengthening pharma’s sustainability foundation
April 8, 2024
New tools can help seamlessly integrate sustainability into R&D and production goals
Editors' (re)View: ALS and drug approval criteria; Verve trial paused again
April 5, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of April 1
Five challenges pharma manufacturers face in 2024
April 2, 2024
The industry must understand and mitigate the impact of short- and long-term obstacles
Vaccines of the future
April 2, 2024
There is a new era of vaccinology in pharma's pipelines
Editors' (re)View: J&J can contest talc scientific evidence; SCOTUS mifepristone hearing met with skepticism
March 29, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 25
Exploring alternative distribution models for pharma supply chains
March 26, 2024
ADMs allow manufacturers to take charge of supply channels to boost efficiency and flexibility
Editors' (re)View: J&J cast-off anti-hypertensive wins approval; Orchard prices MLD therapy at $4.25M
March 22, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 18
Editors' (re)View: FDA shares early AD industry guidance; WuXi-BIO breakup
March 15, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 11
Anticipating AI regulations in pharma manufacturing
March 11, 2024
In a rapidly evolving regulatory landscape, leaders should remain ready to adapt to new legislation
Leveraging lean innovation principles
March 11, 2024
How pharma can apply tactics from other industries to tackle recent policy cost initiatives
Charting a sustainable path for generics
March 8, 2024
Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting
Editors' (re)View: Perrigo launches OTC birth control; Lilly takes aim at celebs
March 8, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 4
Breaking down pharma compliance barriers
March 7, 2024
How pharma companies are solving regulatory challenges with AI-based technology
Navigating the smaller batch market
March 5, 2024
Pharma innovators are using technology to meet the unique demands of today’s small scale era
FDA decisions to watch in 2024
March 5, 2024
This year, the agency will decide on groundbreaking treatments for conditions like Alzheimer's, NASH, pulmonary hypertension and more
5 Pharma changemakers
March 1, 2024
The CNBC 2024 Changemakers list highlighted fifty women as transformative leaders, including five from the pharma industry
Editors' (re)View: Probing pharma-sponsored testing; FDA approves Alvotech-Teva Humira biosim
March 1, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of February 24
Pharma CDMOs with sky-high ambitions
Feb. 29, 2024
A snapshot of the bold CDMOs working to build pharma’s modern treatments
Pharma Manufacturing job function
Feb. 28, 2024
The role of workwear in mitigating pharma workplace hazards
Feb. 28, 2024
Ergonomic clothing explicitly designed for the industry helps avoid common safety incidents, as well as aid in compliance
Matica Biotechnology: Filling the void
Feb. 27, 2024
With a dedication to advanced technologies, the Texas-based CDMO is helping quickly bring cell and gene therapies from idea to patient
INCOG Biopharma: Pedaling towards excellence
Feb. 27, 2024
The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology
Cellares: A disruptive impact on cell therapy
Feb. 27, 2024
The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...
Load More Content